𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Risperidone, olanzapine and quetiapine in the treatment of behavioral and psychological symptoms in patients with Alzheimer's disease: Preliminary findings from a naturalistic, retrospective study

✍ Scribed by PAOLA ROCCA; FEDERICA MARINO; CRISTIANA MONTEMAGNI; DAVIDE PERRONE; FILIPPO BOGETTO


Book ID
108962197
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
70 KB
Volume
61
Category
Article
ISSN
1323-1316

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Quetiapine treatment for behavioural and
✍ D. Paleacu; Y. Barak; I. Mirecky; D. Mazeh 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## Abstract ## Setting Treating elderly patients with Alzheimer's disease (AD) and behavioral and psychological symptoms of dementia (BPSD) is challenging due to the increased risk of iatrogenic movement disorders with old neuroleptics and the seemingly increasing risk of cardiovascular events wit

Olanzapine versus placebo in the treatme
✍ Peter Paul De Deyn; Manuel Martín Carrasco; Walter Deberdt; Claude Jeandel; Dona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 2 views

## Abstract ## Objectives Psychotic symptoms and behavioral disturbances are a concern in the care of elderly patients with Alzheimer's dementia (AD). This study was conducted to compare the efficacy of olanzapine versus placebo in patients with psychotic symptoms associated with AD in long‐term o

Tolerability of extended-release quetiap
✍ Peter Paul De Deyn; Hans Eriksson; Hanna Svensson; on behalf of the Study 115 in 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB 👁 2 views

## Objective The objective of this study was to assess the safety and tolerability of extended‐release quetiapine fumarate (quetiapine XR) compared with quetiapine immediate‐release (quetiapine IR) in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation. ## Methods